Duration of antimicrobial therapy for nosocomial pneumonia: Possible strategies for minimizing antimicrobial use in intensive care units

Journal of Clinical Pharmacy and Therapeutics

Volumn 28, Issue 2, 2003, Pages 123-129

  Dugan, H A ^a   MacLaren, R ^a   Jung, Rose ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Duration of antibiotic therapy; Nosocomial pneumonia; Shorter course

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; VANCOMYCIN;

ANTIMICROBIAL THERAPY; DIAGNOSTIC PROCEDURE; DRUG USE; HOSPITAL; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; PNEUMONIA; PUBLISHING; REDUCTION; REVIEW;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, BACTERIAL;

EID: 0038670216     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2003.00471.x     Document Type: Review

References (25)

1. Vincent JL, Bihari DJ, Suter PM et al. (1995) The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study; EPIC International Advisory Committee. Journal of American Medical Association, 274, 639-644.
2. National Nosocomial Infections Surveillance System (1999) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1990-May 1999, issued June 1999. American Journal of Infection Control, 27, 520-532.
3. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. (1989) Hospital-acquired pneumonia: attributable mortality and morbidity. American Journal of Epidemiology, 129, 1258-1267.
4. Rello J, Rue M, Jubert P, Muses G, Sonora R, Valles J, Niederman MS. (1997) Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Critical Care Medicine, 25, 1862-1867.
5. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. (1999) The attributable morbidity and mortality of ventilator-associated pneumonia in critically-ill patient: the Canadian Critical Trials Group. American Journal of Respiratory Critical Care Medicine, 159, 1249-1256.
6. American Thoracic Society (1995) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. American Journal of Respiratory Critical Care Medicine, 153, 1711-1725.
7. Chastre J, Fagon JY. (2002) Ventilator-associated pneumonia. American Journal of Respiratory Critical Care Medicine, 165, 867-903.
8. Chevret S, Hemmer M, Carlet J, Langer M. (1993) Incidence and risk factors of pneumonia acquired in intensive care units: results from a multicenter prospective study on 996 patients; European Cooperative Group on Nosocomial Pneumonia. Intensive Care Medicine, 19, 256-264.
9. Kollef MH. (2000) Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clinical Infectious Diseases, 31, S131-S138.
10. Bergmans DCJJ, Bonten MJM, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, Stobberingh EE. (1997) Indication for antibiotic use in ICU patients: a one-year prospective surveillance. Journal of Antimicrobial Chemotherapy, 39, 527-535.
11. Freeman J, Rosner BA, McGowan JE Jr. (1979) Adverse effects of nosocomial infection. Journal of Infectious Diseases, 140, 732-740.
12. Brun-Buisson C, Sollet JP, Schweich H, Briere S, Petit C. (1988) Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group. Clinical Infectious Diseases, 26, 346-354.
13. Fink MP, Snydman DR, Niederman MS et al. (1994) Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrobial Agents and Chemotherapy, 38, 547-557.
14. Wolff M. (1998) Comparison of strategies using cefpirome and ceftazidime for empiric treatment of pneumonia in intensive care patients. The Cefpirome Pneumonia Study Group. Antimicrobial Agents Chemotherapy, 42, 28-36.
15. Kollef MH, Sherman G, Ward S, Frazer VJ. (1999) Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients. Chest, 115, 462-474.
16. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest, 122, 262-268.
17. Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH. (1990) Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine, 2, 170-174.
18. Wunderink RG, Woldenberg LS, Zeiss J, Day CM, Ciemins J, Lacher DA. (1992) The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest, 101, 458-463.
19. Johanson WG, Pierce AK, Stanford JP, Thomas GD. (1972) Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Annals of Internal Medicine, 77, 701-706.
20. Singh N, Rogers P, Atwood CW, Wagener MM, Yu V. (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory Critical Care Medicine, 162, 505-511.
21. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew RD, Suter PM. (1991) Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic 'blind' bronchoalveolar lavage fluid. American Review of Respiratory Diseases, 143, 1121-1129.
22. Croce MA, Fabian TC, Schur MJ, Boscarino R, Pritchard FE, Minard G. (1995) Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory-response syndrome: a prospective analysis. Journal of Trauma, 39, 1134-1140.
23. Ibrahim E, Ward S, Sherman G, Schaiff R, Fraser V, Kollef M. (2001) Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Critical Care Medicine, 29, 1109-1115.
24. Fagon JY, Chastre J, Wolff M et al. (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. Annals of Internal Medicine, 132, 621-630.
25. Peery C, Chendrasekhar A, Moorman DW, Timberlake GA. (1999) Ventilator associated pneumonia: therapy based on protected specimen brushing versus tracheal aspirate data. Chest, 16, 278S.